Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian R Phillips

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 25, 2008
Human flavin-containing monooxygenase 2.1 catalyzes oxygenation of the antitubercular drugs thiacetazone and ethionamideAsvi A Francois, Clinton R Nishida, Paul R Ortiz de Montellano, et al.
Optics Letters|May 14, 2021
Material jet printing of transparent ceramic Yb:YAG planar waveguidesZachary M Seeley, Ian R Phillips, Thomas J Rudzik, et al.
Pharmaceuticals (Basel, Switzerland)|April 13, 2013
Metabolism and pharmacokinetics of the anti-tuberculosis drug ethionamide in a flavin-containing monooxygenase null mouseAmy L Palmer, Virginia L Leykam, Andrew Larkin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 25, 2017
Identification of Flavin-Containing Monooxygenase 5 (FMO5) as a Regulator of Glucose Homeostasis and a Potential Sensor of Gut BacteriaFlora Scott, Sandra G Gonzalez Malagon, Brett A O'Brien, et al.
Frontiers in Physiology|August 25, 2022
Treatment of wild-type mice with 2,3-butanediol, a urinary biomarker of <i>Fmo5</i> <sup>-/-</sup> mice, decreases plasma cholesterol and epididymal fat depositionSunil Veeravalli, Dorsa Varshavi, Flora H Scott, et al.
Biochemical Pharmacology|May 6, 2014
The phenotype of a flavin-containing monooyxgenase knockout mouse implicates the drug-metabolizing enzyme FMO1 as a novel regulator of energy balanceSunil Veeravalli, Bilal A Omar, Lyndsey Houseman, et al.
Frontiers in Molecular Biosciences|April 25, 2018
Metabolic Biomarkers of Ageing in C57BL/6J Wild-Type and Flavin-Containing Monooxygenase 5 (FMO5)-Knockout MiceDorsa Varshavi, Flora H Scott, Dorna Varshavi, et al.
Pharmacogenetics and Genomics|September 17, 2008
The potentially deleterious functional variant flavin-containing monooxygenase 2*1 is at high frequency throughout sub-Saharan AfricaKrishna R Veeramah, Mark G Thomas, Michael E Weale, et al.
Drug Metabolism Reviews|September 7, 2002
Genetic polymorphisms of flavin-containing monooxygenase (FMO)Sharon K Krueger, David E Williams, Mei-Fei Yueh, et al.
Biochemical Pharmacology|June 7, 2015
The phenotype of a knockout mouse identifies flavin-containing monooxygenase 5 (FMO5) as a regulator of metabolic ageingSandra G Gonzalez Malagon, Anna N Melidoni, Diana Hernandez, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 25, 2008
Human flavin-containing monooxygenase 2.1 catalyzes oxygenation of the antitubercular drugs thiacetazone and ethionamideAsvi A Francois, Clinton R Nishida, Paul R Ortiz de Montellano, et al.
Optics Letters|May 14, 2021
Material jet printing of transparent ceramic Yb:YAG planar waveguidesZachary M Seeley, Ian R Phillips, Thomas J Rudzik, et al.
Pharmaceuticals (Basel, Switzerland)|April 13, 2013
Metabolism and pharmacokinetics of the anti-tuberculosis drug ethionamide in a flavin-containing monooxygenase null mouseAmy L Palmer, Virginia L Leykam, Andrew Larkin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 25, 2017
Identification of Flavin-Containing Monooxygenase 5 (FMO5) as a Regulator of Glucose Homeostasis and a Potential Sensor of Gut BacteriaFlora Scott, Sandra G Gonzalez Malagon, Brett A O'Brien, et al.
Frontiers in Physiology|August 25, 2022
Treatment of wild-type mice with 2,3-butanediol, a urinary biomarker of <i>Fmo5</i> <sup>-/-</sup> mice, decreases plasma cholesterol and epididymal fat depositionSunil Veeravalli, Dorsa Varshavi, Flora H Scott, et al.
Biochemical Pharmacology|May 6, 2014
The phenotype of a flavin-containing monooyxgenase knockout mouse implicates the drug-metabolizing enzyme FMO1 as a novel regulator of energy balanceSunil Veeravalli, Bilal A Omar, Lyndsey Houseman, et al.
Frontiers in Molecular Biosciences|April 25, 2018
Metabolic Biomarkers of Ageing in C57BL/6J Wild-Type and Flavin-Containing Monooxygenase 5 (FMO5)-Knockout MiceDorsa Varshavi, Flora H Scott, Dorna Varshavi, et al.
Pharmacogenetics and Genomics|September 17, 2008
The potentially deleterious functional variant flavin-containing monooxygenase 2*1 is at high frequency throughout sub-Saharan AfricaKrishna R Veeramah, Mark G Thomas, Michael E Weale, et al.
Drug Metabolism Reviews|September 7, 2002
Genetic polymorphisms of flavin-containing monooxygenase (FMO)Sharon K Krueger, David E Williams, Mei-Fei Yueh, et al.
Biochemical Pharmacology|June 7, 2015
The phenotype of a knockout mouse identifies flavin-containing monooxygenase 5 (FMO5) as a regulator of metabolic ageingSandra G Gonzalez Malagon, Anna N Melidoni, Diana Hernandez, et al.
Pageof 6